- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
Cepheid+ Add to Watchlist
CPHD:US41.6100 USD 0.4850 1.18%
As of 20:10:00 ET on 07/22/2014.
Company Profile for Cepheid (CPHD)
Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.
Key Executives for Cepheid (CPHD)
|John L BishopChairman/CEO||Philippe JaconPresident:High Burden Dev|
|Andrew D MillerExec VP/CFO||David H PersingExec VP/Chief Medical & Tech Ofcr|
|Kerry J FlomExec VP/Chief Regulatory Ofcr||Joseph H SmithExec VP:Corporate Dev/Secy/Gen Cnsl|
|Michael W Fitzgerald "Mike"Exec VP:Global Human Resources||Warren C Kocmond JrExec VP:Global Operations|
|Peter FarrellExec VP:Intl Commercial Ops||James Post "Jim"Exec VP:North American Commercial|
|Jacquie RossInvestor Relations|